A first-in-human clinical trial of an investigational treatment for muscular sclerosis (MS) and systemic scleroderma (SSc) called EHP-101 was successfully completed. The Phase I clinical trial sponsored by Emerald Health Pharmaceuticals (EHP) demonstrated that EHP-101...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
